Investigating the role of the Neogenin-1/Netrin-1 axis in aging and lineage bias of hematopoietic stem cells (HSCs)

研究 Neogenin-1/Netrin-1 轴在造血干细胞 (HSC) 衰老和谱系偏向中的作用

基本信息

  • 批准号:
    9759142
  • 负责人:
  • 金额:
    $ 5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT Hematopoietic stem cells (HSCs) are defined by their ability to long-term reconstitute all blood and immune cells in a transplanted host. However, HSCs are heterogeneous and exhibit different degrees of reconstitution potential and biases towards certain cell lineages. This diversity in HSCs is a function of both intrinsic changes in the cells, such as acquired somatic mutations and epigenetic marks, and external influences such as local bone marrow morphogens and circulating factors in the blood. It is evident from the transplantation of low numbers of purified HSCs that there exist at least two types of HSCs distinguishable by their contribution to different hematopoietic lineages—myeloid-biased HSCs, which contribute more to granulocytes and monocytes than to T, B, and NK cells, and balanced HSCs, which contribute equally to all lineages. During aging, the myeloid-biased subset of HSCs clonally expands and predominates the old bone marrow, leading to impaired blood and immune production and an increased risk of leukemia and preleukemic adverse events. Still, the origin and identity of the myeloid-biased HSCs, much less a method to prospectively separate them from balanced HSCs, is unknown. Recently, we observed that Neogenin-1 (Neo-1), a cell surface receptor, marks a fraction of long-term reconstituting mouse Hoxb5+ HSCs and human CD34+CD38-CD90+CD45RA- HSCs. Serial transplantation of Neo-1+ and Neo-1- Hoxb5+ HSCs into sublethally irradiated hosts reveals that Neo-1 marks stable, myeloid-biased mouse Hoxb5+ HSCs, while Neo-1- Hoxb5+ HSCs are balanced or lymphoid-biased. Neo- 1+ Hoxb5+ HSCs also formed larger colonies in vitro and were more often in G2/S than Neo-1- Hoxb5+ HSCs. Furthermore, Netrin-1, a chemoattractant molecule and ligand to Neo-1, is expressed in bone marrow endothelial cells and its depletion in mice results in reduced number of myeloid cells in the peripheral blood compared to wildtype controls. Given this evidence, two specific aims are proposed: (1) To identify the functional and transcriptional differences between Neo-1+ and Neo-1- HSCs during mouse and human aging, and (2) To determine the bone marrow localization and characterize the myeloid-priming function of endothelial Netrin-1. Percent expansion and gene expression differences will be measured between Neo-1+ and Neo-1- HSCs in mice and humans with age. Aged Neo-1+ and Neo-1- Hoxb5+ HSCs will be transplanted into conditioned mice and their total and lineage chimerism will be compared to our data from young Neo-1+ and Neo-1- Hoxb5+ transplants. Furthermore, bone marrow from Hoxb5-mCherry mice will be imaged to localize Netrin-1-expressing cells, and the effect of Netrin-1 deletion in endothelial cells will be evaluated. These studies will provide novel information on HSC heterogeneity and stem cell reconstitution and advance our understanding of aging in hematopoiesis.
项目摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gunsagar Singh Gulati其他文献

Gunsagar Singh Gulati的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了